Our Team Business Leadership Charles L. Dimmler, III Executive Chairman, Board of Directors Entrepreneur and venture capitalist with 30+ years of operating leadership experience in biopharma businesses Julia Busik, PhD, FARVO Chief Scientific Officer, Chief of Scientific and Medical Advisory Board World authority on diabetic retinopathy with 20+ years of experience leading research programs Galina Vid, PhD Vice President, Operations Pharmaceutical strategist with 20+ years of industry experience spanning research and business development Lisa Janicki, CPA Controller Financial expert with 25+ years of experience leading financial functions for early-stage companies Scientific and Medical Advisory Board Julia Busik, PhD, FARVO Chief Scientific Officer, Chief of Scientific and Medical Advisory Board World authority on diabetic retinopathy with 20+ years of experience leading research programs Lloyd Paul Aiello MD, PhD Member, Scientific and Medical Advisory Board Esteemed ophthalmologist with over 30 years of experience developing interventions for diabetic retinal diseases Patricia A. D’Amore, PhD, MBA, FARVO Member, Scientific and Medical Advisory Board Global leader in vascular growth and development research with 30+ years of experience Consultants and Business Advisors Linda Law, MD, MBA Development, Medical, and Commercial Strategy Consultant Medical affairs specialist with 25+ years of clinical development leadership experience James M. Joly, PhD Preclinical Safety and Toxicology Consultant Industry veteran with 35+ years of experience leading preclinical safety development programs Kira Manusis, MD Competitive Strategy Advisor Practicing ophthalmologist with 20+ years of experience, specializing in cornea, external disease, and refractive surgery Thomas J. MacVittie, PhD Radiation Research Consultant Renowned radiobiology expert with 40+ years of experience developing medical countermeasures CMC Consultant Bioprocess development expert with 27+ years of industry experience Clinical Development Consultant Board-certified pharmacologist with 25 years of biopharmaceutical development experience Regulatory Consultant Regulatory affairs expert with over 25 years of government and industry experience Board of Directors Charles L. Dimmler, III Executive Chairman, Board of Directors Entrepreneur and venture capitalist with 30+ years of operating leadership experience in biopharma businesses James Tanenbaum Director, Board of Directors Leading capital markets lawyer with 40+ years of experience Rob Brown, MBA Director, Board of Directors Marketing expert with 30+ years of pharmaceutical leadership experience Elliott J. Sussman, MD, MBA Director, Board of Directors Healthcare expert with decades of experience advancing patient care and transforming healthcare delivery Team Members Samia Mohammed, PhD Research Scientist I Molecular biologist specializing in sphingolipid signaling pathways Olivia Beane, PhD Project Manager Biotechnology professional with expertise in preclinical product development
Charles L. Dimmler, III Executive Chairman, Board of Directors Entrepreneur and venture capitalist with 30+ years of operating leadership experience in biopharma businesses
Julia Busik, PhD, FARVO Chief Scientific Officer, Chief of Scientific and Medical Advisory Board World authority on diabetic retinopathy with 20+ years of experience leading research programs
Galina Vid, PhD Vice President, Operations Pharmaceutical strategist with 20+ years of industry experience spanning research and business development
Lisa Janicki, CPA Controller Financial expert with 25+ years of experience leading financial functions for early-stage companies
Julia Busik, PhD, FARVO Chief Scientific Officer, Chief of Scientific and Medical Advisory Board World authority on diabetic retinopathy with 20+ years of experience leading research programs
Lloyd Paul Aiello MD, PhD Member, Scientific and Medical Advisory Board Esteemed ophthalmologist with over 30 years of experience developing interventions for diabetic retinal diseases
Patricia A. D’Amore, PhD, MBA, FARVO Member, Scientific and Medical Advisory Board Global leader in vascular growth and development research with 30+ years of experience
Linda Law, MD, MBA Development, Medical, and Commercial Strategy Consultant Medical affairs specialist with 25+ years of clinical development leadership experience
James M. Joly, PhD Preclinical Safety and Toxicology Consultant Industry veteran with 35+ years of experience leading preclinical safety development programs
Kira Manusis, MD Competitive Strategy Advisor Practicing ophthalmologist with 20+ years of experience, specializing in cornea, external disease, and refractive surgery
Thomas J. MacVittie, PhD Radiation Research Consultant Renowned radiobiology expert with 40+ years of experience developing medical countermeasures
Clinical Development Consultant Board-certified pharmacologist with 25 years of biopharmaceutical development experience
Regulatory Consultant Regulatory affairs expert with over 25 years of government and industry experience
Charles L. Dimmler, III Executive Chairman, Board of Directors Entrepreneur and venture capitalist with 30+ years of operating leadership experience in biopharma businesses
James Tanenbaum Director, Board of Directors Leading capital markets lawyer with 40+ years of experience
Rob Brown, MBA Director, Board of Directors Marketing expert with 30+ years of pharmaceutical leadership experience
Elliott J. Sussman, MD, MBA Director, Board of Directors Healthcare expert with decades of experience advancing patient care and transforming healthcare delivery
Samia Mohammed, PhD Research Scientist I Molecular biologist specializing in sphingolipid signaling pathways
Olivia Beane, PhD Project Manager Biotechnology professional with expertise in preclinical product development
